When overall survival fails to confirm event-free survival, should the latter be used to set the standard of care?

J Clin Oncol. 2014 Dec 20;32(36):4173-4. doi: 10.1200/JCO.2014.58.1678. Epub 2014 Nov 17.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bone Marrow Transplantation*
  • Humans
  • Isotretinoin / therapeutic use*
  • Neuroblastoma / therapy*

Substances

  • Isotretinoin